Krankenhaushygiene up2date, Table of Contents Krankenhaushygiene up2date 2016; 11(01): 63-77DOI: 10.1055/s-0042-102405 Nosokomiale Infektionen © Georg Thieme Verlag KG Stuttgart · New YorkPrävention von Clostridium-difficile-Infektionen Susanne Kolbe-Busch Recommend Article Abstract Buy Article All articles of this category Full Text References Literatur 1 Leffler DA, Lamont JT. Clostridium difficile Infection. Review Article. N Engl J Med 2015; 372: 1539-48 2 Lessa FC, Mu Y, Bamberg WM et al. Burden of Clostridium difficile Infection in the United States. N Engl J Med 2015; 372: 825-834 3 Miller MA, Hyland M, Ofner-Agostini M. Canadian Hospital Epidemiology Committee et al. Canadian Nosocomial Infection Surveillance Program. Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals. Infect Control Hosp Epidemiol 2002; 23: 137-140 4 Barbut F, Mastrantonio P, Delmée M et al. Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect 2007; 13: 1048-1057 5 Zarb P, Coignard B, Griskeviciene J et al. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveill 2012; 17: pii: 20316 6 Hansen S, Sohr D, Piening B et al. Antibiotic usage in German hospitals: results of the second national prevalence study. J Antimicorb Chemother 2013; 68: 2934-2939 7 Gastmeier P, Kampf G, Wischnewski N et al. Prevalence of nosocomial infections in representative German hospitals. J Hosp Infect 1998; 38: 37-49 8 Hall IC, O'Toole E. Intestinal flora in newborn infants with a description of a new pathogenic anaerobe Bacillus difficilis. Am J Dis Child 1935; 49: 390 9 George RH, Symonds JM, Dimock F et al. Identification of Clostridium difficile as a cause of pseudomembranous colitis. Br Med J 1978; 1: 695 10 Bagdasarian N, Rao K, Malani PN. Diagnosis and Treatment of Clostridium difficile in Adults. A Systemativ Review. JAMA 2015; 313: 398-408 11 Jangi S, Lamont JT. Asymptomatic Colonization by Clostridium difficile in Infants: Implications for Disease in Later Life. Journal of Pediatric Gastroenterology and Nutrition 2010; 51: 2-7 12 Kyne L, Warny M, Qamar A et al. Asymptomatic Carriage of Clostridium difficile and Serum Levels of IgG Antibody against Toxin A. N Engl J Med 2000; 342: 390-397 13 See I, Mu Y, Cohen J et al. NAP1 strain type predicts outcomes from Clostridium difficile infection. Clin Infect Dis 2014; 58: 1394-1400 14 Freeman J, Bauer MP, Baines SD et al. The Changing Epidemiology of Clostridium difficile Infections. Clin Microbiol Rev 2010; 23: 529-549 15 Slimings C, Riley TV. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother 2014; 69: 881-891 16 Mitchell BG, Dancer SJ, Anderson M et al. Risk of organism acquisition from prior room occupants: a systematic review and meta-analysis. J Hosp Infect 2015; 91: 211-217 17 Eyre DW, Cule ML, Wilson DJ et al. Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med 2013; 369: 1195-1205 18 Mermel LA. Diverse Sources of C. difficile Infection. N Engl J Med 2014; 370: 182-183 19 Evans CT, Safdar N. Current trends in the epidemiology and outcomes of Clostridium difficile infection. Clin Infect Dis 2015; 60: 66-72 20 Eyre DW, Babakhani F, Griffiths D et al. Whole-genome sequencing demonstrates that fidaxomicin is superior to vancomycin for preventing reinfection and relapse of infection with Clostridium difficile. J Infect Dis 2014; 209: 1446-1451 21 Kuntz JL, Chrischilles EA, Pendergast JF et al. Incidence of and risk factors for community-associated Clostridium difficile infection: A nested case-control study. BMC Infect Dis 2011; 11: 194 22 Schaumann R, Rodloff A. Clostridium spp. In: Neumeister B, Geiss K, Braun RW. et al., Hrsg. Mikrobiologische Diagnostik. 2. Aufl. Stuttgart: Thieme; 2009: 546-548 23 Davies KA, Longshaw ChM, Davis GL et al. Underdiagnosis of Clostridium difficile across Europe: the European multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect Dis 2014; 14: 1208-1219 24 Crobach MJT, Dekkers OM, Wilcox MH et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect 2009; 15: 1053-1066 25 Aguado JM. Highlighting clinical needs in Clostridium difficile infection: the views of European healthcare professionals at the front line. J Hosp Infect 2015; 90: 117-125 26 Joost I, Speck K, Herrmann M et al. Characterisation of Clostridium difficile isolates by slpA and tcdC gene sequencing. Int J Antimicrob Agents 2009; 33 (Suppl. 01) 13-18 27 Knight DR, Elliott B, Chang BJ et al. Diversity and Evolution in the Genome of Clostridium difficile. Clin Microbiol Rev 2015; 28: 721-41 28 He M, Miyajima F, Roberts P et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet 2013; 45: 109-113 29 Warny M, Pepin J, Fang A et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005; 366: 1079-1084 30 Public Health England. Annual Epidemiological Commentary: Mandatory MRSA, MSSA and E. coli bacteraemia and C. difficile infection data, 2014/15. Online: 2015 https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/442952/Annual_Epidemiological_Commentary_FY_2014_2015.pdf (letzter Zugriff: 2.2.2016) 31 Kuijper EJ, van den Berg RJ, Debast S et al. Clostridium difficile Ribotype 027, Toxinotype III, the Netherlands. Emerg Infect Dis 2006; 12: 827-830 32 Zaiß NH, Weile J, Ackermann G et al. A case of Clostridium difficile-associated disease due to the highly virulent clone of Clostridium difficile PCR ribotype 027, March 2007 in Germany. Euro Surveill 2007; 12: pii 3306 33 Kleinkauf N, Weiss B, Jansen A et al. Confirmed cases and report of clusters of severe infections due to Clostridium difficile PCR ribotype 027 in Germany. Euro Surveill 2007; 12: pii 3307 34 Bauer MP, Notermans DW, van Benthem BH et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011; 377: 63-73 35 Von Müller L, Mock M, Halfmann A et al. Epidemiology of Clostridium difficile in Germany based on a single center long-term surveillance and German-wide genotyping of recent isolates provided to the advisory laboratory for diagnostic reasons. Int J Med Microbiol 2015; 305: 807-813 36 Robert Koch-Institut. Clostridium difficile Ratgeber für Ärzte. Stand: 17.8.2011. Online: https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Clostridium.html (letzter Zugriff: 2.2.2016) 37 Vonberg RP, Kuijper EJ, Wilcox MH et al. Infection control measures to limit the spread of Clostridium difficile. CMI 2008; 2-20 38 Martin M, Zingg W, Knoll E. PROHIBIT Study Group et al. National European guidelines for the prevention of Clostridium difficile infection: a systematic qualitative review. J Hosp Infect 2014; 87: 212-219 39 Dubberke ER, Carling P, Carrico R et al. Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals: 2014 Update. SHEA/IDSA Practice Recommendation. ICHE 2014; 35: 628-645 40 Guyatt GH, Oxman AD, Vist GE et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-926 41 De With K, Allerberger F, Amann S et al. S3-Leitlinie: Strategien zur Sicherung rationaler Antibiotika-Anwendung im Krankenhaus AWMF-Registernummer 092/001. Stand: 1.12.2013. Online: http://www.awmf.org/leitlinien/detail/ll/092-001.html (letzter Zugriff: 2.2.2016) 42 Feazel LM, Malhotra A, Perencevich EN et al. Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis. J Antimicrob Chemother 2014; 69: 1748-1754 43 Dubberke ER. Preventing Clostridium difficile infection: Clarifying Common Misperceptions. Medscape. 2015 Online: http://www.medscape.com/viewarticle/841721 (letzter Zugriff: 2.2.2016) 44 Gastmeier P, Weitzel-Kage D, Behnke M et al. Surveillance of Clostridium difficile-associated diarrhoea with the German nosocomial infection surveillance system KISS (CDAD-KISS). Int J Antimicrob Agents 2009; 33: 19-23 45 Nationales Referenzzentrum für Surveillance von nosokomialen Infektionen (NRZ). Web KESS-Portal für KISS. Online: https://webkess.charite.de/webKess2/de-DE//Home/Index (letzter Zugriff: 2.2.2016) 46 Robert Koch-Institut. Bekanntmachung: Surveillance nosokomialer Infektionen sowie die Erfassung von Krankheitserregern mit speziellen Resistenzen und Multiresistenzen. Bundesgesundheitsbl 2013; 56: 580-583 47 Robert Koch-Institut. Schwer verlaufende Clostridium-difficile-Infektionen: IfSG-Surveillancedaten. Epidemiologisches Bulletin 2014; 27 48 Bundesministerium für Gesundheit. Bekämpfung resistenter Erreger: 10-Punkte-Plan zur Vermeidung behandlungsassoziierter Infektionen und Antibiotika-Resistenzen. Online: http://www.bmg.bund.de/ministerium/meldungen/2015/10-punkte-plan-zu-antibiotika-resistenzen.html (letzter Zugriff: 2.2.2016) 49 Bundesärztekammer. Stellungnahme: Referentenentwurf des Bundesministeriums für Gesundheit einer Verordnung zur Anpassung der Meldepflichten nach dem Infektionsschutzgesetz an die epidemische Lage (IfSG-Meldepflicht-Anpassungsverordnung – IfSG-MeldAnpV). 2015 Online: http://www.bundesaerztekammer.de/fileadmin/user_upload/downloads/Stn_BAeK_IfSG-Meldepflicht-Anpassungsverordnung_17.03.2015.pdf (letzter Zugriff: 2.2.2016)
